Invion
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAInvion Limited (IVX) is involved the global research and development of the Photosoft technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand license and distribution rights to the Photosoft technology. Research and clinical trials are funded by the technology licensor, The Cho Group, via an R&D services agreement with the Company. The Group has operations in Australia and the United States with its wholly owned subsidiaries Invion Inc., Chronic Airway Therapeutics Limited and IVX Cosmetics Pty Ltd.
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 879th |  | Invion | $4.1m |
| 1038th | | Bio-Gene Technology | $595k |
| 1041st | | Linius Technologies | $558k |
| 1048th | | Kangaroo Island Plantation Timbers | $483k |
| 1052nd | | CD Private Equity Fund I | $422k |
1328 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 548th | CD Private Equity Fund I | 8% | 14% |
| 656th | Linius Technologies | 1% | -42% |
| 1150th | Invion | -29% | -19% |
| 1553rd | Bio-Gene Technology | -55% | -16% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEW ROLE: T Chew, | 30 Oct 2023 |
| NEW ROLE: C Newton, Chief Executive Officer | 24 Nov 2020 |
| NEW ROLE: T Coogan, | 24 Nov 2020 |
| NEW ROLE: Melanie Leydin, Chief Financial Officer, Company Secretary | 03 Nov 2020 |
| NEW ROLE: Chiat T Chew, Chief Executive Officer, Executive Chairman, Executive Director | 03 Nov 2020 |
| NEW ROLE: Alan Yamashita, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Rob Merriel, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Alistair Bennallack, Non-Executive Director | 03 Nov 2020 |
